UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial

Lancet neurology, 2016-04, Vol.15 (4), p.373-381

2016

Volltextzugriff (PDF)

The FINISH-3 Trial: A Phase 3, International, Randomized, Single-Blind, Controlled Trial of Topical Fibrocaps in Intraoperative Surgical Hemostasis

Journal of the American College of Surgeons, 2015, Vol.220 (1), p.70-81

2015

Volltextzugriff (PDF)

Results From the First‐in‐Human Study With Ozanimod, a Novel, Selective Sphingosine‐1‐Phosphate Receptor Modulator

Journal of clinical pharmacology, 2017-08, Vol.57 (8), p.988-996

2017

Volltextzugriff (PDF)

Results From a First‐in‐Human Study of BNZ‐1, a Selective Multicytokine Inhibitor Targeting Members of the Common Gamma (γc) Family of Cytokines

Journal of clinical pharmacology, 2020-02, Vol.60 (2), p.264-273

2020

Volltextzugriff (PDF)

UB-311, a novel UBITh amyloid β peptide vaccine for mild Alzheimer's disease

Alzheimer's & dementia : translational research & clinical interventions, 2017-06, Vol.3 (2), p.262-272

2017

Volltextzugriff (PDF)

Cardiac Safety of Ozanimod, a Novel Sphingosine‐1‐Phosphate Receptor Modulator: Results of a Thorough QT/QTc Study

Clinical pharmacology in drug development, 2018-03, Vol.7 (3), p.263-276

2018

Volltextzugriff (PDF)

Effects of High‐ and Low‐Fat Meals on the Pharmacokinetics of Ozanimod, a Novel Sphingosine‐1‐Phosphate Receptor Modulator

Clinical pharmacology in drug development, 2018-08, Vol.7 (6), p.634-640

2018

Volltextzugriff (PDF)

445 The TOUCHSTONE Study: A Randomized, Double-Blind, Placebo-Controlled Induction Trial of an Oral S1P Receptor Modulator (RPC1063) in Moderate to Severe Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-93-S-93

2015

Volltextzugriff (PDF)

445 The TOUCHSTONE Study: a Randomized, Double-Blind, Placebo-Controlled Induction Trial of an Oral S1P Receptor Modulator (RPC1063) in Moderate to Severe Ulcerative Colitis

Gastrointestinal endoscopy, 2015-05, Vol.81 (5), p.AB147-AB147

2015

Volltextzugriff (PDF)

Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis

The New England journal of medicine, 2016-05, Vol.374 (18), p.1754-1762

2016

Volltextzugriff (PDF)

Abstract CT034: Activation of the antitumor immune response of gamma9delta2 T cells in patients with solid or hematologic malignancies with ICT01, a first-in-class, monoclonal antibody targeting butyrophilin 3A: The EVICTION study

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT034-CT034

2021

Volltextzugriff (PDF)

Effects of High- and Low-Fat Meals on the Pharmacokinetics of Ozanimod, a Novel Sphingosine 1-Phosphate Receptor Modulator: 650

The American journal of gastroenterology, 2016-10, Vol.111, p.S298

2016

Volltextzugriff (PDF)

Safety and Efficacy of Long-Term Treatment with Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Touchstone Extension: 571

The American journal of gastroenterology, 2016-10, Vol.111, p.S262

2016

Volltextzugriff (PDF)

A Randomized, Double-Blind, Placebo-Controlled Trial of a Novel Recombinant, Humanized, Anti-Interleukin-13 Monoclonal Antibody (RPC4046) in Patients with Active Eosinophilic Esophagitis: Results of the HEROES Study: 420

The American journal of gastroenterology, 2016-10, Vol.111, p.S186

2016

Volltextzugriff (PDF)

The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys

Movement disorders, 1997-03, Vol.12 (2), p.148-158

1997

Volltextzugriff (PDF)

Functional and Molecular Differentiation of the Dopamine System Induced by Neonatal Denervation

Neuroscience and biobehavioral reviews, 1996, Vol.20 (3), p.453-486

1996

Volltextzugriff (PDF)

Delayed plasticity of the mesolimbic dopamine system following neonatal 6-OHDA lesions

Synapse (New York, N.Y.), 1997-03, Vol.25 (3), p.293-305

1997

Volltextzugriff (PDF)

Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism

Synapse (New York, N.Y.), 1995-01, Vol.19 (1), p.46-55

1995

Volltextzugriff (PDF)

Marked Digoxin-Likeimmunoreactive Factor Interference with an Enzyme Immunoassay

Drug intelligence & clinical pharmacy, 1988-09, Vol.22 (9), p.703-705

1988

Volltextzugriff (PDF)

Comparison of a Bayesian program with three microcomputer programs for predicting gentamicin concentrations

Therapeutic drug monitoring, 1988, Vol.10 (3), p.287-291

1988

Volltextzugriff (PDF)

Local nanoscale phase impurities are degradation sites in halide perovskites

Nature (London), 2022-07, Vol.607 (7918), p.294-300

2022

Volltextzugriff (PDF)

Nanoscale chemical heterogeneity dominates the optoelectronic response of alloyed perovskite solar cells

Nature nanotechnology, 2022-02, Vol.17 (2), p.190-196

2022

Volltextzugriff (PDF)

Nanoscale chemical heterogeneity dominates the optoelectronic response of alloyed perovskite solar cells

Nature nanotechnology, 2022-02, Vol.17 (2), p.190-196

2022

Volltextzugriff (PDF)

Stabilized tilted-octahedra halide perovskites inhibit local formation of performance-limiting phases

Science (American Association for the Advancement of Science), 2021-12, Vol.374 (6575), p.1598-1605

2021

Volltextzugriff (PDF)

Local nanoscale phase impurities are degradation sites in halide perovskites

Nature (London), 2022-07, Vol.607 (7918), p.294-300

2022

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(69)
Dissertationen
(1)

Sprache

Englisch
(70)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial

The FINISH-3 Trial: A Phase 3, International, Randomized, Single-Blind, Controlled Trial of Topical Fibrocaps in Intraoperative Surgical Hemostasis

Results From the First‐in‐Human Study With Ozanimod, a Novel, Selective Sphingosine‐1‐Phosphate Receptor Modulator

Results From a First‐in‐Human Study of BNZ‐1, a Selective Multicytokine Inhibitor Targeting Members of the Common Gamma (γc) Family of Cytokines

UB-311, a novel UBITh amyloid β peptide vaccine for mild Alzheimer's disease

Cardiac Safety of Ozanimod, a Novel Sphingosine‐1‐Phosphate Receptor Modulator: Results of a Thorough QT/QTc Study

Effects of High‐ and Low‐Fat Meals on the Pharmacokinetics of Ozanimod, a Novel Sphingosine‐1‐Phosphate Receptor Modulator

445 The TOUCHSTONE Study: A Randomized, Double-Blind, Placebo-Controlled Induction Trial of an Oral S1P Receptor Modulator (RPC1063) in Moderate to Severe Ulcerative Colitis

445 The TOUCHSTONE Study: a Randomized, Double-Blind, Placebo-Controlled Induction Trial of an Oral S1P Receptor Modulator (RPC1063) in Moderate to Severe Ulcerative Colitis

Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis

Abstract CT034: Activation of the antitumor immune response of gamma9delta2 T cells in patients with solid or hematologic malignancies with ICT01, a first-in-class, monoclonal antibody targeting butyrophilin 3A: The EVICTION study

Effects of High- and Low-Fat Meals on the Pharmacokinetics of Ozanimod, a Novel Sphingosine 1-Phosphate Receptor Modulator: 650

Safety and Efficacy of Long-Term Treatment with Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Touchstone Extension: 571

A Randomized, Double-Blind, Placebo-Controlled Trial of a Novel Recombinant, Humanized, Anti-Interleukin-13 Monoclonal Antibody (RPC4046) in Patients with Active Eosinophilic Esophagitis: Results of the HEROES Study: 420

The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys

Functional and Molecular Differentiation of the Dopamine System Induced by Neonatal Denervation

Delayed plasticity of the mesolimbic dopamine system following neonatal 6-OHDA lesions

Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism

Marked Digoxin-Likeimmunoreactive Factor Interference with an Enzyme Immunoassay

Comparison of a Bayesian program with three microcomputer programs for predicting gentamicin concentrations

Local nanoscale phase impurities are degradation sites in halide perovskites

Nanoscale chemical heterogeneity dominates the optoelectronic response of alloyed perovskite solar cells

Nanoscale chemical heterogeneity dominates the optoelectronic response of alloyed perovskite solar cells

Stabilized tilted-octahedra halide perovskites inhibit local formation of performance-limiting phases

Local nanoscale phase impurities are degradation sites in halide perovskites

Suchergebnisse filtern